Remembering Evan Sadler (1951 – 2018)
Evan Sadler III, MD, PhD, the Lang Professor of Medicine and Chief of Hematology at Washington University in St. Louis, passed away on December 13, 2018, after a brief but devastating illness.
Dr. Sadler was born in West Virginia and, after graduating from Princeton University, he earned his MD/PhD from Duke University in 1978, training in enzymology and protein biochemistry. Dr. Sadler remained at Duke for his internal medicine residency, then completed a hematology fellowship at the University of Washington in Seattle.
During his fellowship, he became interested in normal and disordered blood coagulation, successfully cloning von Willebrand factor for his research fellowship project. Later, he pioneered the study of the proteins von Willebrand factor and ADAMTS13, and his research led to a more comprehensive understanding, improved diagnosis, and better treatment of von Willebrand disease, thrombocytopenic purpura, and other clotting and bleeding disorders.
In 1984, Dr. Sadler joined the faculty of Washington University, where he remained for his entire career. He was appointed director of the division of hematology in 2009 and named the Ira M. Lang Professor of Medicine in 2014.
Throughout his career, Dr. Sadler received several awards and honors in recognition of his contributions to the field of hematology. He was granted a Howard Hughes Medical Institute investigatorship, which he held for 25 years, and he was a member of the National Academy of Medicine.
Most recently, the American Society of Hematology (ASH), for which he served as president in 2011, awarded him the 2018 Exemplary Service Award for his years of service and dedication to the Society. He also received ASH’s Henry M. Stratton Medal for Basic Science in 2016 and the William Dameshek Prize in 1998.
In The Hematologist, colleagues Kenneth Kaushansky, MD, and David Ginsburg, MD, remembered Dr. Sadler as an example of “quintessential collegiality”: “It never mattered to Evan who did something first or got the credit – what really mattered was solving the scientific problem at hand in the most rigorous fashion. He was a caring mentor to over 50 trainees in his own lab as well as innumerable trainees and junior faculty members at his own and other institutions.”
Dr. Sadler is survived by his wife, Linda J. Pike, PhD, the Alumni Endowed Professor of Biochemistry and Molecular Biophysics at Washington University; daughter, Brooke E. Sadler, PhD; son, Evan D. Sadler, PhD; his mother, Clara Rose Sadler; and two grandsons, Jasper and Dexter Haller.
“Evan Sadler was a scientific and clinical giant in the field of hemostasis, whose contributions to biomedical research and to patient care will live long after him,” Drs. Kaushansky and Ginsburg continued. “He was also a wonderfully kind, generous, and warm human being who will be profoundly missed by so many.”
Source: The Hematologist; Washington University School of Medicine in St. Louis.
Remembering Charles E. Dobbs (1934 – 2018)
Charles E. Dobbs MD, an Emeritus member of the American Society of Hematology, passed away on December 16, 2018.
Dr. Dobbs grew up in Charleston, West Virginia, and graduated from Duke University Medical School. He completed his internship and residency in internal medicine at Vanderbilt University Hospital, and his fellowship in hematology at Washington University in St. Louis and the University of Miami in Florida. He also served two years in the U.S. Navy at the Naval Hospital in Portsmouth, Virginia.
In 1965, he joined the practice of Marion F. Beard, MD, and Ellis A. Fuller, MD, in Louisville, where he practiced for 38 years, retiring in 2003. During his career, Dr. Dobbs was associated with many hospitals in the Louisville area, establishing the first oncology unit in the state of Kentucky at Highlands Baptist Hospital and the Comprehensive Cancer Center at Baptist Health Louisville.
In addition to membership with ASH, Dr. Dobbs was active in several professional societies, including serving as president of the Kentucky Division of the American Cancer Society.
Dr. Dobbs is survived by his wife of 60 years, two sons, a daughter, and four grandchildren.
Source: The Courier-Journal.
Temple University Awarded NCI Grant to Study Cancer Health Disparities
The National Cancer Institute awarded a five-year, $13.5-million grant to the Lewis Katz School of Medicine at Temple University and Hunter College of the City University of New York to support research on cancer health inequity among minority populations. The award supports the creation of the Temple University Fox Chase Cancer Center and Hunter College Regional Comprehensive Cancer Health Disparities Partnership.
More than 70 investigators across both organizations will be involved with the new partnership. The joint efforts will focus on three core areas: multidisciplinary cancer research; diversifying the research and medical pipeline by training and mentoring minority junior faculty and students; and educating and engaging the community. Community outreach initiatives include holding cancer screenings and overcoming the barriers that contribute to cancer disparities, like proximity to care, economic issues, health literacy, stigma, stress, and mental health.
Source: Temple University press release, October 30, 2018.
Emory University Names New Director of Cardio-Oncology Program
Anant Mandawat, MD, was appointed director of the cardio-oncology program at Winship Cancer Institute of Emory University and Emory University’s Division of Cardiology. The program was established in 2011 to address the cardiovascular consequences of cancer and cancer therapies and to care for the heart health of cancer survivors.
Dr. Mandawat holds positions as an assistant professor in the departments of Hematology and Medical Oncology and Medicine at Emory University. In this role, Dr. Mandawat will work collaboratively with colleagues at both organizations to improve outcomes for patients undergoing treatment and for survivors who are being followed in the Winship Survivorship Program.
Source: Emory University press release, October 17, 2018.
Richard Drachtman Receives Distinguished Service Award
The Melvyn H. Motolinsky Research Foundation named Richard Drachtman, MD, the recipient of its Distinguished Service Award, which was established to support research into leukemia and other hematologic diseases.
Dr. Drachtman is clinical section chief of the pediatric hematology/oncology division at Rutgers Cancer Institute of New Jersey and professor of pediatrics at Rutgers Robert Wood Johnson Medical School. He also is director of the Rutgers Robert Wood Johnson Medical School Regional Comprehensive Sickle Cell Center.
The award acknowledged his research into and expertise in childhood Hodgkin lymphoma and sickle cell disease.
Source: Rutgers University press release, November 4, 2018.